Other Liabilities, Noncurrent of CUMBERLAND PHARMACEUTICALS INC from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
CUMBERLAND PHARMACEUTICALS INC quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • CUMBERLAND PHARMACEUTICALS INC Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $5,951,386, a 2.3% decline year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

CUMBERLAND PHARMACEUTICALS INC Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,951,386 -$139,336 -2.3% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $6,301,166 -$237,804 -3.6% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $6,005,853 -$604,441 -9.1% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $6,299,795 -$153,771 -2.4% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $6,090,722 -$364,369 -5.6% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $6,538,970 -$415,236 -6% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $6,610,294 -$481,004 -6.8% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $6,453,566 -$1,131,453 -15% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $6,455,091 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $6,954,206 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $7,091,298 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $7,585,019 +$96,175 +1.3% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q4 2021 $7,488,844 -$373,928 -4.8% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q4 2020 $7,862,772 -$874,551 -10% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q4 2019 $8,737,323 -$581,820 -6.2% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $9,319,143 +$7,503,175 +413% 31 Dec 2018 8-K 10 Dec 2020
Q4 2017 $1,815,968 +$424,484 +31% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $1,391,484 +$404,055 +41% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $987,429 +$84,588 +9.4% 31 Dec 2015 10-K 13 Mar 2017 2016 FY
Q4 2014 $902,841 +$126,716 +16% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 $776,125 +$164,192 +27% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q4 2012 $611,933 +$33,814 +5.8% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q4 2011 $578,119 31 Dec 2011 10-K 12 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.